Singular Genomics Systems Inc (OMIC) Stock

DelistedNasdaq: OMICSingular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine.

20.01
Final close · Feb 20, 2025

OMIC is no longer traded. Singular Genomics Systems was delisted from the Nasdaq in February 2025.

Prices on this page are historical; the last trade was February 20, 2025 at $20.01.

Singular Genomics Systems stock price history

Split-adjusted closes, 2021–2025

OMIC final trading statistics

Final close
$20.01
Final trading day
Feb 20, 2025
Market cap at delisting
$50.77M
Shares outstanding
2.54M
Final 52-week range
$0.27 – $23.41
Avg. volume (final 3 mo.)
13,609
All-time high (split-adj.)
$935.10 · Jun 2021
All-time low (split-adj.)
$5.65 · Sep 2024
Return since IPO
-97.6%
Beta
1.83
Book value / share
$49.16
Price / book
0.41
Final 52 wk
0.2723.41

Singular Genomics Systems earnings per share

Earnings per share

Singular Genomics Systems revenue & net income

RevenueNet income

Singular Genomics Systems annual financials

Singular Genomics Systems Inc revenue, net income and EPS by fiscal year
Fiscal yearRevenueNet incomeEPS
FY2023$2.91M-$94.8M-$1.31
FY2022$765.0K-$88.3M-$1.27
FY2021$0.00-$98.9M-$1.35
FY2020$0.00-$28.7M-$2.05
FY2019$0.00-$12.3M-$0.52

Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.

About Singular Genomics Systems Inc

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. It is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. The company was incorporated in 2016 and is based in San Diego, California. As of February 21, 2025, Singular Genomics Systems, Inc. was taken private.

Singular Genomics Systems stock FAQ

What happened to Singular Genomics Systems stock?

Singular Genomics Systems stock was delisted from the Nasdaq. Its final close was $20.01 on February 20, 2025.

Is OMIC stock still trading?

No. OMIC was delisted from the Nasdaq in February 2025 and no longer trades on a U.S. exchange.

What was the last price of OMIC stock?

OMIC closed at $20.01 on its final trading day, February 20, 2025, for a market value of about $50.77M.

What were Singular Genomics Systems's revenue and earnings in its last full fiscal year?

Singular Genomics Systems reported revenue of $2.91M and net income of -$94.8M in fiscal 2023, its last full year as a public company.

When did Singular Genomics Systems go public?

Singular Genomics Systems Inc stock began trading on May 27, 2021.

Medical Instruments & Supplies stocks to research

All Healthcare stocks →